The city of Cambridge in Massachusetts saw Vor Bio (Nasdaq: VOR), a company specializing in autoimmune disease treatments, reveal its involvement in a fireside chat and virtual 1x1 investor gatherings at the Stifel 2025 Virtual Immunology and Inflammation Forum on September 12, 2025. This event marks a significant step for the clinical-stage biotechnology firm as it continues to develop innovative approaches to combat autoimmune diseases.